Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease.

NCT00930423 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT00930423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00930423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease.
Lead sponsor
University Hospital, Ghent
Phase
Observational
Overall status
Completed
Start date
August 31, 2009
Completion date
July 31, 2015
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypical hemolytic uraemic syndrome